Top 5 Infectious Disease News Stories Week of June 7-June 14
FDA Expands Moderna’s mRNA-1345 RSV Vaccine to Younger Adults The FDA has expanded approval of Moderna’s mRNA-1345 (mRESVIA) respiratory syncytial virus (RSV) vaccine to include adults aged 18 to 59 years, following its initial approval for those 60 and older to prevent lower respiratory tract disease caused by RSV. This decision was based on Moderna’s […]
